StemBioSys, Inc. of San Antonio, TX at MEDICA 2020 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option

StemBioSys, Inc.

3463 Magic Drive, Suite 110, 78229 San Antonio, TX
USA

This company is co-exhibitor of
State of Texas

Contact

Iris Flores

Phone
210-877-9323

Email
Iris.flores@stembiosys.com

Our range of products

Product categories

  • 02  Laboratory technology
  • 02.13  Microplate, microtiter plates

Microplate, microtiter plates

  • 02  Laboratory technology
  • 02.24  Other laboratory equipment

Other laboratory equipment

  • 03  Diagnostic tests
  • 03.03  Haematology / histology / cytology testing
  • 03.03.02  Histology reagents, cytology reagents

Histology reagents, cytology reagents

Company news

Date

Topic

Download

Nov 16, 2020

CeLLvo Matrix



The centerpiece of these technologies is CELLvo™ Matrix.  This cell-derived microenvironment allows a variety of cells to replicate more rapidly, maintain phenotype over multiple passages and express markers indicative of potency beyond that seen with traditional tissue culture substrates.  The company also manufactures several cell products isolated and expanded on our matrix. 

Our suite of products promote confidence in preclinical safety and drug toxicity screening and StemBioSys will continue to develop solutions that simply scientific progress.

More Less

About us

Company details

StemBioSys is a privately held biotechnology company whose technologies represent the next evolution in cell research. Products are branded under the CELLvo™ name.

The centerpiece of these technologies is CELLvo™ Matrix.  This cell-derived microenvironment allows a variety of cells to replicate more rapidly, maintain phenotype over multiple passages and express markers indicative of potency beyond that seen with traditional tissue culture substrates.  The company also manufactures several cell products isolated and expanded on our matrix. 

Our suite of products promote confidence in preclinical safety and drug toxicity screening and StemBioSys will continue to develop solutions that simply scientific progress.

More Less